GHO debuts with DNA Diagnostics
The Europe-focused healthcare firm’s acquisition of DNA Diagnostics is its first from its debut fund.
13 October 2015•2 mins read
The Europe-focused healthcare firm’s acquisition of DNA Diagnostics is its first from its debut fund.
PEI Private Equity Awards 2026: Send us your highlights!
5 November 2026 · 6 mins read
Side Letter: Blended buyouts
3 November 2026 · 3 mins read
Deep Dive: Why Asia-Pacific private equity is shifting from growth to control
2 November 2026 · 10 mins read
Ardian bets on the ‘power of live’ in latest buyout fund
28 October 2026 · 3 mins read
Japanese GP returns entire debut fund with first exit
29 September 2026 · 2 mins read
Carlyle leans into carve-outs as dealmaking gets more competitive
24 September 2026 · 3 mins read
Number Crunch: The road to cyber resilience
22 September 2026 · 3 mins read
